Effectiveness and Safety of Iguratimod in Treating Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis

Effectiveness and Safety of Iguratimod in Treating Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis

Objectives: We aimed to assess the effectiveness and safety of iguratimod (IGU) in treating primary Sjögren’s syndrome (pSS) by meta-analysis.Methods: Eight databases and two clinical trial websites were searched from conception to August 10, 2020, for relevant randomized controlled trials (RCTs) on...

Full description

Bibliographic Details
Main Authors: Jincheng Pu, Xuan Wang, Farooq Riaz, Tongyangzi Zhang, Ronglin Gao, Shengnan Pan, Zhenzhen Wu, Yuanyuan Liang, Shuqi Zhuang, Jianping Tang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Pharmacology
Subjects:
iguratimod
primary Sjögren’s syndrome
effectiveness
safety
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.621208/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.621208/full

Similar Items